Trials / Unknown
UnknownNCT03986008
Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this studay is to evaluate the effects of Benaglutide on the treatment of subjects with obesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Benaglutide | The treatment of Benaglutide lasted three months.During the first week: 0.1mg per day;During the second week: 0.14mg per day; From third week onwards, 0.2mg per day. |
| DRUG | Liraglutide | The treatment of Liraglutide lasted three months.During the first week: 0.6mg per day;During the second week: 1.2mg per day; From third week onwards, 1.8mg per day. |
Timeline
- Start date
- 2019-12-01
- Primary completion
- 2021-12-23
- Completion
- 2021-12-23
- First posted
- 2019-06-14
- Last updated
- 2021-04-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03986008. Inclusion in this directory is not an endorsement.